{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T15:35:05Z","timestamp":1791300905424,"version":"4.1.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2008,6,3]],"date-time":"2008-06-03T00:00:00Z","timestamp":1212451200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2008,8]]},"DOI":"10.1007\/s00213-008-1172-1","type":"journal-article","created":{"date-parts":[[2008,6,2]],"date-time":"2008-06-02T06:43:35Z","timestamp":1212389015000},"page":"275-289","source":"Crossref","is-referenced-by-count":51,"title":["The antipsychotic potential of l-stepholidine\u2014a naturally occurring dopamine receptor D1 agonist and D2 antagonist"],"prefix":"10.1007","volume":"199","author":[{"given":"Sridhar","family":"Natesan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Greg E.","family":"Reckless","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen B. L.","family":"Barlow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Odontiadis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 N.","family":"Nobrega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glen B.","family":"Baker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan R.","family":"George","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Mamo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shitij","family":"Kapur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,6,3]]},"reference":[{"issue":"Suppl 1","key":"1172_CR1","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1017\/S1461145704004110","volume":"7","author":"A Abi-Dargham","year":"2004","unstructured":"Abi-Dargham A (2004) Do we still believe in the dopamine hypothesis? New data bring new evidence. Int J Neuropsychopharmacol 7(Suppl 1):S1\u20135","journal-title":"Int J Neuropsychopharmacol"},{"key":"1172_CR2","doi-asserted-by":"crossref","first-page":"3708","DOI":"10.1523\/JNEUROSCI.22-09-03708.2002","volume":"22","author":"A Abi-Dargham","year":"2002","unstructured":"Abi-Dargham A, Mawlawi O, Lombardo I, Gil R, Martinez D, Huang Y, Hwang DR, Keilp J, Kochan L, Van Heertum R, Gorman JM, Laruelle M (2002) Prefrontal dopamine D1 receptors and working memory in schizophrenia. J Neurosci 22:3708\u20133719","journal-title":"J Neurosci"},{"key":"1172_CR3","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1007\/s00213-001-0933-x","volume":"159","author":"M Aravagiri","year":"2002","unstructured":"Aravagiri M, Marder SR (2002) Brain, plasma and tissue pharmacokinetics of risperidone and 9-hydroxyrisperidone after separate oral administration to rats. Psychopharmacology (Berl) 159:424\u2013431","journal-title":"Psychopharmacology (Berl)"},{"key":"1172_CR4","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/1099-081X(199911)20:8<369::AID-BDD200>3.0.CO;2-6","volume":"20","author":"M Aravagiri","year":"1999","unstructured":"Aravagiri M, Teper Y, Marder SR (1999) Pharmacokinetics and tissue distribution of olanzapine in rats. Biopharm Drug Dispos 20:369\u2013377","journal-title":"Biopharm Drug Dispos"},{"key":"1172_CR5","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0893-133X(97)00112-7","volume":"18","author":"J Arnt","year":"1998","unstructured":"Arnt J, Skarsfeldt T (1998) Do novel antipsychotics have similar pharmacological characteristics? A review of the evidence. Neuropsychopharmacology 18:63\u2013101","journal-title":"Neuropsychopharmacology"},{"key":"1172_CR6","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/0014-2999(92)90690-6","volume":"213","author":"J Arnt","year":"1992","unstructured":"Arnt J, Hyttel J, Sanchez C (1992) Partial and full dopamine D1 receptor agonists in mice and rats: relation between behavioural effects and stimulation of adenylate cyclase activity in vitro. Eur J Pharmacol 213:259\u2013267","journal-title":"Eur J Pharmacol"},{"key":"1172_CR7","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1126\/science.287.5460.2020","volume":"287","author":"SA Castner","year":"2000","unstructured":"Castner SA, Williams GV, Goldman-Rakic PS (2000) Reversal of antipsychotic-induced working memory deficits by short-term dopamine D1 receptor stimulation. Science 287:2020\u20132022","journal-title":"Science"},{"key":"1172_CR8","first-page":"442","volume":"13","author":"LJ Chen","year":"1992","unstructured":"Chen LJ, Guo X, Wang QM, Jin GZ (1992) Feed-back regulation of presynaptic D2 receptors blockaded by l-stepholidine and l-tetrahydropalmatine. Acta Pharmacol Sin 13:442\u2013445","journal-title":"Acta Pharmacol Sin"},{"key":"1172_CR9","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.pbb.2005.06.006","volume":"81","author":"RI Desai","year":"2005","unstructured":"Desai RI, Terry P, Katz JL (2005) A comparison of the locomotor stimulant effects of D1-like receptor agonists in mice. Pharmacol Biochem Behav 81:843\u2013848","journal-title":"Pharmacol Biochem Behav"},{"key":"1172_CR10","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0006-2952(97)00152-4","volume":"54","author":"ZJ Dong","year":"1997","unstructured":"Dong ZJ, Chen LJ, Jin GZ, Creese I (1997a) GTP regulation of (\u2212)-stepholidine binding to R(H) of D1 dopamine receptors in calf striatum. Biochem Pharmacol 54:227\u2013232","journal-title":"Biochem Pharmacol"},{"key":"1172_CR11","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S0024-3205(97)00404-9","volume":"61","author":"ZJ Dong","year":"1997","unstructured":"Dong ZJ, Guo X, Chen LJ, Han YF, Jin GZ (1997b) Dual actions of (\u2212)-stepholidine on the dopamine receptor-mediated adenylate cyclase activity in rat corpus striatum. Life Sci 61:465\u2013472","journal-title":"Life Sci"},{"key":"1172_CR12","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1124\/dmd.104.001230","volume":"33","author":"A Doran","year":"2005","unstructured":"Doran A, Obach RS, Smith BJ, Hosea NA, Becker S, Callegari E, Chen C, Chen X, Choo E, Cianfrogna J, Cox LM, Gibbs JP, Gibbs MA, Hatch H, Hop CE, Kasman IN, Laperle J, Liu J, Liu X, Logman M, Maclin D, Nedza FM, Nelson F, Olson E, Rahematpura S, Raunig D, Rogers S, Schmidt K, Spracklin DK, Szewc M, Troutman M, Tseng E, Tu M, Van Deusen JW, Venkatakrishnan K, Walens G, Wang EQ, Wong D, Yasgar AS, Zhang C (2005) The impact of P-glycoprotein on the disposition of drugs targeted for indications of the central nervous system: evaluation using the MDR1A\/1B knockout mouse model. Drug Metab Dispos 33:165\u2013174","journal-title":"Drug Metab Dispos"},{"key":"1172_CR13","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1111\/j.1745-7254.2006.00365.x","volume":"27","author":"BA Ellenbroek","year":"2006","unstructured":"Ellenbroek BA, Zhang XX, Jin GZ (2006) Effects of (\u2212)stepholidine in animal models for schizophrenia. Acta Pharmacol Sin 27:1111\u20131118","journal-title":"Acta Pharmacol Sin"},{"key":"1172_CR14","volume-title":"Probit analysis","author":"DJ Finney","year":"1971","unstructured":"Finney DJ (1971) Probit analysis. Cambridge University Press, London"},{"key":"1172_CR15","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1093\/schbul\/sbi041","volume":"31","author":"SB Floresco","year":"2005","unstructured":"Floresco SB, Geyer MA, Gold LH, Grace AA (2005) Developing predictive animal models and establishing a preclinical trials network for assessing treatment effects on cognition in schizophrenia. Schizophr Bull 31:888\u2013894","journal-title":"Schizophr Bull"},{"key":"1172_CR16","volume-title":"The mouse brain in stereotaxic coordinates","author":"KBJ Franklin","year":"1997","unstructured":"Franklin KBJ, Paxinos G (1997) The mouse brain in stereotaxic coordinates. Academic, San Diego"},{"key":"1172_CR17","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0165-0173(99)00045-4","volume":"31","author":"PS Goldman-Rakic","year":"2000","unstructured":"Goldman-Rakic PS, Muly EC 3rd, Williams GV (2000) D1 receptors in prefrontal cells and circuits. Brain Res Brain Res Rev 31:295\u2013301","journal-title":"Brain Res Brain Res Rev"},{"key":"1172_CR18","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1097\/00001756-200211150-00019","volume":"13","author":"H Guo","year":"2002","unstructured":"Guo H, Yu Y, Xing L, Jin GZ, Zhou J (2002) (\u2212)-Stepholidine promotes proliferation and neuronal differentiation of rat embryonic striatal precursor cells in vitro. Neuroreport 13:2085\u20132089","journal-title":"Neuroreport"},{"key":"1172_CR19","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/sj.npp.1380111","volume":"11","author":"H Hall","year":"1994","unstructured":"Hall H, Sedvall G, Magnusson O, Kopp J, Halldin C, Farde L (1994) Distribution of D1- and D2-dopamine receptors, and dopamine and its metabolites in the human brain. Neuropsychopharmacology 11:245\u2013256","journal-title":"Neuropsychopharmacology"},{"key":"1172_CR20","first-page":"32","volume":"12","author":"KX Huang","year":"1991","unstructured":"Huang KX, Sun BC, Gonon FG, Jin GZ (1991) Effects of tetrahydroprotoberberines on dopamine release and 3,4-dihydroxyphenylacetic acid level in corpus striatum measured by in vivo voltammetry. Acta Pharmacol Sin 12:32\u201336","journal-title":"Acta Pharmacol Sin"},{"key":"1172_CR21","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0893-133X(98)00060-8","volume":"20","author":"JD Jentsh","year":"1999","unstructured":"Jentsh JD, Roth RH (1999) The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia. Neuropsychopharmacology 20:201\u2013225","journal-title":"Neuropsychopharmacology"},{"key":"1172_CR22","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0165-6147(87)90076-9","volume":"8","author":"GZ Jin","year":"1987","unstructured":"Jin GZ (1987) (\u2212)-Tetrahydropalmatine and its analogues as new dopamine receptor antagonists. Trends Pharmacol Sci 8:81\u201382","journal-title":"Trends Pharmacol Sci"},{"key":"1172_CR23","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/978-1-4615-1857-0_5","volume":"363","author":"GZ Jin","year":"1995","unstructured":"Jin GZ, Sun BC (1995) Neuropharmacological effects of (\u2212)-stepholidine and its analogues on brain dopaminergic system. Adv Exp Med Biol 363:27\u201328","journal-title":"Adv Exp Med Biol"},{"issue":"Suppl","key":"1172_CR24","doi-asserted-by":"crossref","first-page":"175S","DOI":"10.1016\/0197-0186(92)90234-I","volume":"20","author":"GZ Jin","year":"1992","unstructured":"Jin GZ, Huang KX, Sun BC (1992) Dual actions of (\u2212)-stepholidine on dopamine receptor subtypes after substantia nigra lesion. Neurochem Int 20(Suppl):175S\u2013178S","journal-title":"Neurochem Int"},{"key":"1172_CR25","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/S0165-6147(00)01929-5","volume":"23","author":"GZ Jin","year":"2002","unstructured":"Jin GZ, Zhu ZT, Fu Y (2002) (\u2212)-Stepholidine: a potential novel antipsychotic drug with dual D1 receptor agonist and D2 receptor antagonist actions. Trends Pharmacol Sci 23:4\u20137","journal-title":"Trends Pharmacol Sci"},{"key":"1172_CR26","first-page":"81","volume":"2","author":"JM Kane","year":"2003","unstructured":"Kane JM, Malhotra A (2003) The future of pharmacotherapy for schizophrenia. World Psychiatry 2:81\u201386","journal-title":"World Psychiatry"},{"key":"1172_CR27","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1124\/jpet.102.046987","volume":"305","author":"S Kapur","year":"2003","unstructured":"Kapur S, VanderSpek SC, Brownlee BA, Nobrega JN (2003) Antipsychotic dosing in preclinical models is often unrepresentative of the clinical condition: a suggested solution based on in vivo occupancy. J Pharmacol Exp Ther 305:625\u2013631","journal-title":"J Pharmacol Exp Ther"},{"key":"1172_CR28","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/0306-4522(91)90003-7","volume":"40","author":"MS Lidow","year":"1991","unstructured":"Lidow MS, Goldman-Rakic PS, Gallager DW, Rakic P (1991) Distribution of dopaminergic receptors in the primate cerebral cortex: quantitative autoradiographic analysis using [3H]raclopride, [3H]spiperone and [3H]SCH23390. Neuroscience 40:657\u2013671","journal-title":"Neuroscience"},{"key":"1172_CR29","first-page":"65","volume":"51","author":"J Liu","year":"1999","unstructured":"Liu J, Guo X, Wang BC, Jin GZ (1999) Increased phosphorylation of DARPP-32 by D1 agonistic action of l-stepholidine in the 6-OHDA-lesioned rat striatum. Acta Physiologica Sinica 51:65\u201372","journal-title":"Acta Physiologica Sinica"},{"key":"1172_CR30","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/syn.10108","volume":"46","author":"FN McNamara","year":"2002","unstructured":"McNamara FN, Clifford JJ, Tighe O, Kinsella A, Drago J, Fuchs S, Croke DT, Waddington JL (2002) Phenotypic, ethologically based resolution of spontaneous and D2-like vs D1-like agonist-induced behavioural topography in mice with congenic D(3) dopamine receptor \u201cknockout\u201d. Synapse 46:19\u201331","journal-title":"Synapse"},{"key":"1172_CR31","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/sj.npp.1300628","volume":"30","author":"YQ Mo","year":"2005","unstructured":"Mo YQ, Jin XL, Chen YT, Jin GZ, Shi WX (2005) Effects of l-stepholidine on forebrain Fos expression: comparison with clozapine and haloperidol. Neuropsychopharmacology 30:261\u2013267","journal-title":"Neuropsychopharmacology"},{"key":"1172_CR32","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1038\/sj.npp.1300983","volume":"31","author":"S Natesan","year":"2006","unstructured":"Natesan S, Reckless GE, Nobrega JN, Fletcher PJ, Kapur S (2006) Dissociation between in vivo occupancy and functional antagonism of dopamine D(2) receptors: comparing aripiprazole to other antipsychotics in animal models. Neuropsychopharmacology 31:1854\u20131863","journal-title":"Neuropsychopharmacology"},{"key":"1172_CR33","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.jchromb.2006.11.039","volume":"850","author":"J Odontiadis","year":"2007","unstructured":"Odontiadis J, Mackenzie EM, Natesan S, Mamo D, Kapur S, Baker GB (2007) Quantification of l-stepholidine in rat brain and plasma by high performance liquid chromatography combined with fluorescence detection. J Chromatogr B Analyt Technol Biomed Life Sci 850:544\u2013547","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"1172_CR34","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1038\/385634a0","volume":"385","author":"Y Okubo","year":"1997","unstructured":"Okubo Y, Suhara T, Suzuki K, Kobayashi K, Inoue O, Terasaki O, Someya Y, Sassa T, Sudo Y, Matsushima E, Iyo M, Tateno Y, Toru M (1997) Decreased prefrontal dopamine D1 receptors in schizophrenia revealed by PET. Nature 385:634\u2013636","journal-title":"Nature"},{"key":"1172_CR35","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/S0006-8993(01)03152-3","volume":"922","author":"CM Olsen","year":"2001","unstructured":"Olsen CM, Duvauchelle CL (2001) Intra-prefrontal cortex injections of SCH 23390 influence nucleus accumbens dopamine levels 24 h post-infusion. Brain Res 922:80\u201386","journal-title":"Brain Res"},{"key":"1172_CR36","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/syn.20107","volume":"55","author":"GJ O\u2019Sullivan","year":"2005","unstructured":"O\u2019Sullivan GJ, Kinsella A, Sibley DR, Tighe O, Croke DT, Waddington JL (2005) Ethological resolution of behavioural topography and D1-like versus D2-like agonist responses in congenic D5 dopamine receptor mutants: identification of D5:D2-like interactions. Synapse 55:201\u2013211","journal-title":"Synapse"},{"key":"1172_CR37","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1002\/syn.20225","volume":"59","author":"GJ O\u2019Sullivan","year":"2006","unstructured":"O\u2019Sullivan GJ, Kinsella A, Grandy DK, Tighe O, Croke DT, Waddington JL (2006) Ethological resolution of behavioral topography and D2-like vs. D1-like agonist responses in congenic D4 dopamine receptor \u201cknockouts\u201d: identification of D4:D1-like interactions. Synapse 59:107\u2013118","journal-title":"Synapse"},{"key":"1172_CR38","volume-title":"The rat brain in stereotaxic coordinates","author":"G Paxinos","year":"1986","unstructured":"Paxinos G, Watson C (1986) The rat brain in stereotaxic coordinates. Academic, New York"},{"key":"1172_CR39","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1073\/pnas.0604049104","volume":"104","author":"AJ Rashid","year":"2007","unstructured":"Rashid AJ, So CH, Kong MM, Furtak T, El-Ghundi M, Cheng R, O\u2019Dowd BF, George SR (2007) D1\u2013D2 dopamine receptor heterooligomers with unique pharmacology are coupled to rapid activation of Gq\/11 in the striatum. Proc Natl Acad Sci U S A 104:654\u2013659","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1172_CR40","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1002\/cne.20717","volume":"493","author":"TW Robbins","year":"2005","unstructured":"Robbins TW (2005) Chemistry of the mind: neurochemical modulation of prefrontal cortical function. J Comp Neurol 493:140\u2013146","journal-title":"J Comp Neurol"},{"key":"1172_CR41","first-page":"1058","volume":"271","author":"GS Robertson","year":"1994","unstructured":"Robertson GS, Matsumura H, Fibiger HC (1994) Induction patterns of Fos-like immunoreactivity in the forebrain as predictors of atypical antipsychotic activity. J Pharmacol Exp Ther 271:1058\u20131066","journal-title":"J Pharmacol Exp Ther"},{"key":"1172_CR42","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1124\/mol.105.012153","volume":"68","author":"JP Ryman-Rasmussen","year":"2005","unstructured":"vhRyman-Rasmussen JP, Nichols DE, Mailman RB (2005) Differential activation of adenylate cyclase and receptor internalization by novel dopamine D1 receptor agonists. Mol Pharmacol 68:1039\u20131048","journal-title":"Mol Pharmacol"},{"key":"1172_CR43","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1124\/mol.105.012229","volume":"68","author":"CH So","year":"2005","unstructured":"So CH, Varghese G, Curley KJ, Kong MM, Alijaniaram M, Ji X, Nguyen T, O\u2019Dowd BF, George SR (2005) D1 and D2 dopamine receptors form heterooligomers and cointernalize after selective activation of either receptor. Mol Pharmacol 68:568\u2013578","journal-title":"Mol Pharmacol"},{"key":"1172_CR44","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/BF02247715","volume":"109","author":"P Terry","year":"1992","unstructured":"Terry P, Katz JL (1992) Differential antagonism of the effects of dopamine D1-receptor agonists on feeding behavior in the rat. Psychopharmacology (Berl) 109:403\u2013409","journal-title":"Psychopharmacology (Berl)"},{"key":"1172_CR45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/jpet.106.104463","volume":"320","author":"JD Urban","year":"2007","unstructured":"Urban JD, Clarke WP, von Zastrow M, Nichols DE, Kobilka B, Weinstein H, Javitch JA, Roth BL, Christopoulos A, Sexton PM, Miller KJ, Spedding M, Mailman RB (2007) Functional selectivity and classical concepts of quantitative pharmacology. J Pharmacol Exp Ther 320:1\u201313","journal-title":"J Pharmacol Exp Ther"},{"key":"1172_CR46","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1007\/s002130000466","volume":"150","author":"ML Wadenberg","year":"2000","unstructured":"Wadenberg ML, Kapur S, Soliman A, Jones C, Vaccarino F (2000) Dopamine D2 receptor occupancy predicts catalepsy and the suppression of conditioned avoidance response behavior in rats. Psychopharmacology (Berl) 150:422\u2013429","journal-title":"Psychopharmacology (Berl)"},{"key":"1172_CR47","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/BF01062109","volume":"6","author":"K Yamaoka","year":"1978","unstructured":"Yamaoka K, Nakagawa T, Uno T (1978) Statistical moments in pharmacokinetics. J Pharmacokinet Biopharm 6:547\u2013558","journal-title":"J Pharmacokinet Biopharm"},{"key":"1172_CR48","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1177\/1073858405279692","volume":"11","author":"CR Yang","year":"2005","unstructured":"Yang CR, Chen L (2005) Targeting prefrontal cortical dopamine D1 and N-methyl-d-aspartate receptor interactions in schizophrenia treatment. Neuroscientist 11:452\u2013470","journal-title":"Neuroscientist"},{"key":"1172_CR49","first-page":"289","volume":"11","author":"ZD Zhang","year":"1990","unstructured":"Zhang ZD, Zhou CM, Jin GZ, Zhang X, Yang L (1990) Pharmacokinetics and autoradiography of [3H] or [14C]stepholidine. Acta Pharmacol Sin 11:289\u2013292","journal-title":"Acta Pharmacol Sin"},{"key":"1172_CR50","first-page":"532","volume":"40","author":"X Zhang","year":"1997","unstructured":"Zhang X, Sun BC, Jin GZ (1997) Atypical neuroleptic properties of l-stepholidine. Science in China (Series C) 40:532\u2013538","journal-title":"Science in China (Series C)"},{"key":"1172_CR51","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.neulet.2005.04.016","volume":"383","author":"L Zhang","year":"2005","unstructured":"Zhang L, Zhou R, Xiang G (2005) Stepholidine protects against H2O2 neurotoxicity in rat cortical neurons by activation of Akt. Neurosci Lett 383:328\u2013332","journal-title":"Neurosci Lett"},{"key":"1172_CR52","first-page":"663","volume":"21","author":"ZT Zhu","year":"2000","unstructured":"Zhu ZT, Wu WR, Fu Y, Jin GZ (2000) I-stepholidine facilitates inhibition of mPFC DA receptors on subcortical NAc DA release. Acta Pharmacol Sin 21:663\u2013667","journal-title":"Acta Pharmacol Sin"},{"key":"1172_CR53","first-page":"311","volume":"17","author":"LL Zou","year":"1996","unstructured":"Zou LL, Chen Y, Song YY, Jin GZ (1996) Effect of (\u2212)-stepholidine on serum prolactin level of female rats. Acta Pharmacol Sin 17:311\u2013314","journal-title":"Acta Pharmacol Sin"},{"key":"1172_CR54","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0006-2952(97)00153-6","volume":"54","author":"LL Zou","year":"1997","unstructured":"Zou LL, Liu J, Jin GZ (1997) Involvement of receptor reserve in D1 agonistic action of (\u2212)-stepholidine in lesioned rats. Biochem Pharmacol 54:233\u2013240","journal-title":"Biochem Pharmacol"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-008-1172-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00213-008-1172-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-008-1172-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,6]],"date-time":"2020-05-06T02:53:21Z","timestamp":1588733601000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00213-008-1172-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,6,3]]},"references-count":54,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,8]]}},"alternative-id":["1172"],"URL":"https:\/\/doi.org\/10.1007\/s00213-008-1172-1","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,6,3]]}}}